8.39
+0.43(+5.40%)
Currency In USD
| Previous Close | 7.96 |
| Open | 7.95 |
| Day High | 8.42 |
| Day Low | 7.91 |
| 52-Week High | 19.09 |
| 52-Week Low | 7.39 |
| Volume | 794,615 |
| Average Volume | 1.42M |
| Market Cap | 810.72M |
| PE | -16.45 |
| EPS | -0.51 |
| Moving Average 50 Days | 8.46 |
| Moving Average 200 Days | 12.6 |
| Change | 0.43 |
If you invested $1000 in Avadel Pharmaceuticals plc (AVDL) 10 years ago, it would be worth $479.15 as of March 14, 2025 at a share price of $8.39. Whereas If you bought $1000 worth of Avadel Pharmaceuticals plc (AVDL) shares 5 years ago, it would be worth $1,519.93 as of March 14, 2025 at a share price of $8.39.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
GlobeNewswire Inc.
Mar 05, 2025 1:00 PM GMT
DUBLIN, Ireland, March 05, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the foll
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3
GlobeNewswire Inc.
Feb 24, 2025 9:05 PM GMT
DUBLIN, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m.
Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales
GlobeNewswire Inc.
Feb 24, 2025 1:00 PM GMT
DUBLIN, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced that Kevin Springman has joined the company as Vice President of Sales.